Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  vindesine
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-25 of 118 for your search:
Start Over
Trial for Treatment of Adult Patients With Standard Risk Acute Lymphoblastic Leukemia With Chemotherapy and Rituximab
Phase: Phase IV
Type: Treatment
Status: Completed
Age: 15 to 65
Sponsor: Other
Protocol IDs: GMALL03, NCT00199004
German Multicenter Trial for the Treatment of Newly Diagnosed T-lymphoblastic Lymphoma in Adults
Phase: Phase IV
Type: Treatment
Status: Completed
Age: 15 to 65
Sponsor: Other
Protocol IDs: GMALL04, NCT00199017
Phase II-III Vindesine Therapy by Single Dose vs Continuous Infusion for Refractory Metastatic Breast Cancer
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: MDA-MBDT-7848
Phase II/III Chemotherapy with Continuous 5-Day Vindesine Infusion for Metastatic Renal Carcinoma
Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: no age specified
Sponsor:
Protocol IDs: MDA-DT-7913
Phase II/III cis-Platinum in 2-Drug and 3-Drug Combinations with VP-16 and DAVA for Advanced non-Oat Cell Carcinoma of the Lung
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: MDA-DT-8075, NCI-D81-043-098
Phase II/III Chemotherapy with CAMP (CTX/ADR/MTX/PCB) vs VP-16/DAVA/CACP vs VP-16/CACP vs DAVA/CACP for Stage III Metastatic non-Small Cell Bronchogenic Carcinoma
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: under 70
Sponsor:
Protocol IDs: UCCRC-3248, NCI-D81-014-080
Phase III Comparison of 5-Day Continuous Infusions of DAVA vs VBL vs VCR for Metastatic Breast Cancer
Phase: Phase III
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: MDA-MBDT-8008
Combination Chemotherapy Compared With No Treatment Following Surgery in Treating Patients With Non-small Cell Lung Cancer
Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 to 75
Sponsor: Other
Protocol IDs: CDR0000065002, FRE-IALT, EU-96010, NCT00002823
Radiation Therapy With or Without Chemotherapy After Surgery in Treating Patients With Stage IB or Stage IIA Cervical Cancer
Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: EORTC-55954, MRC-CE04, COSA, EU-98061, NSGO-CC-9502, NCT00003209
Combination Chemotherapy Plus Steroid Therapy in Treating Children With Acute Lymphoblastic Leukemia or Lymphoblastic Non-Hodgkin's Lymphoma
Phase: Phase III
Type: Treatment
Status: Closed
Age: Under 18
Sponsor: Other
Protocol IDs: CDR0000066840, EORTC-58951, NCT00003728
Phase III Combination Chemotherapy with VCMP (VCR/L-PAM/CTX/PRED) vs Alternating Courses of VCMP and BEAP (BCNU/DAVA/ADR/PRED) for Previously Untreated Multiple Myeloma
Phase: Phase III
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: NCI-83-C-106, NCI-NMOB-834, NCI-T83-1019N
Phase III VCR vs DAVA with L-ASP/PRED for Reinduction and with CTX for Maintenance for Acute Lymphocytic Leukemia in Children
Phase: Phase III
Type: Treatment
Status: Completed
Age: under 18
Sponsor: NCI
Protocol IDs: CCG-172
Phase III CAMP (CTX/ADR/MTX/PCB) vs MVP (MITO/VBL/CACP) vs DAVA/CACP vs VP-16/CACP for Metastatic non-Small Cell Bronchogenic Carcinoma
Phase: Phase III
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: EST-1581
Phase III Induction Chemotherapy with ADR/DAVA vs ADR Alone for Recurrent or Metastatic Soft Tissue Sarcomas
Phase: Phase III
Type: Treatment
Status: Closed
Age: 14 and over
Sponsor: NCI
Protocol IDs: EST-2782
Phase III Intravenous Chemotherapy with DAVA/5-FU/MITO-C vs HAI Chemotherapy with DAVA/FUDR/MITO-C for Dukes D Colorectal Carcinoma with Liver Metastases
Phase: Phase III
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: MDA-DT-8029
Phase III Randomized Evaluation of Surgery plus Pre- and Postoperative Adjuvant Chemotherapy with DVB (CACP/BLEO/DAVA) vs Surgery Alone for Esophageal Carcinoma
Phase: Phase III
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: NCI-81-C-118, NCI-T83-0978N, T83-0978
Phase III Combination Chemotherapy with CACP/DAVA/MeGAG for Metastatic or Recurrent Epidermoid Carcinoma of the Esophagus
Phase: Phase III
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: MSKCC-8241
Phase III Chemotherapy with DAVA/CACP vs CAP (CTX/ADR/CACP) vs Supportive Care Only in the Management of Extensive non-Small Cell Carcinoma of the Lung
Phase: Phase III
Type: Treatment
Status: Closed
Age: under 70
Sponsor:
Protocol IDs: CAN-NCIC-BR5, NCI-V83-0066, BR5
Phase III Chemotherapy with DAVA vs Radiotherapy vs DAVA plus Radiotherapy for Limited non-Small Cell Lung Cancer
Phase: Phase III
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: SEG-81LUN373
Phase III Chemotherapy with VP (DAVA/CACP) vs MVP (MITO/DAVA/CACP) in Patients with Stage III non-Small Cell Lung Cancer Previously Untreated with Chemotherapy
Phase: Phase III
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: MSKCC-8474, NCI-T84-0409D, T84-0409
Start Over